Empowering Medical Research with Artificial Intelligence on advanced cell culture model
Your Partner in AI Imaging Processing and High Throughput Drug Screening Pipeline.
From early discovery through translational research, we help research teams establish reliable cell-culture models, validate drug candidates, and identify biological mechanisms at the early preclinical stage.
Our integrated platform combines customized microfluidic microwell culture, automated wet-lab procedures, and AI-powered image-processing workflows for scientific research. Our standardized workflow provides an affordable solution for small and medium-sized research teams seeking access to high-throughput, automated drug-screening pipelines supported by artificial intelligence for drug development and biological research.
Our standardized cell-culture platform provides a consistent and scalable environment for establishing organoid and other advanced single cell-based models.
Customized microfluidic microwell geometry helps control cell and organoid positioning, while the 96-well format supports parallel experiments for drug screening, disease modeling, toxicity assessment, and translational research.
By reducing well-to-well variation and improving compatibility with automated handling and microscopy, the platform helps research teams generate more reproducible experimental results.
Combined with AI-powered image processing, it enables researchers to monitor organoid growth, morphology, viability, and treatment response over time.